Analysis promising for keratectasia

Article

Diagnostic platform combines anterior surface topography, corneal tomography data

An analysis combining information from anterior Placido topography and corneal tomography obtained using a proprietary corneal imaging diagnostic platform (Orbscan II, Bausch + Lomb) has shown high sensitivity and specificity for discriminating between Placido negative eyes with forme fruste keratoconus (FFKC) and normal controls, and shows promise as a clinically useful tool for early diagnosis of keratectasia, said Dr Damien Gatinel, PhD.

"Our investigation shows that in eyes where there is no suspicion of keratoconus based on objective analysis of the anterior topography, evaluation of corneal tomography data may sometimes reveal an underlying ectatic condition," he added.

"Answering the question of what technique is superior for early detection of keratectasiasusceptible corneas requires welldesigned investigations. These must use a pertinent clinical model and appropriate statistical methods," Dr Gatinel said.

"These studies must include corneas with known keratectasia susceptibility, and to achieve maximum specificity and sensitivity, they must use discriminant analysis that evaluates the method's performance in separating the study groups and so minimizes false negatives and false positives," he explained.

Borrowing from Dr Stephen D. Klyce, PhD, who stated that the fellow eye of a patient with unilateral keratoconus should be considered as having FFKC, Dr Gatinel suggested that the fellow 'normal' represents the perfect false negative model for discriminant analysis studies.

"As Dr Klyce said, although the FFKC eye has no clinical findings of keratoconus and is Placido negative, it has genetic susceptibility to keratoconus and is considered to have subclinical keratoconus," he said.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.